BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 29-Jan-2018

(Q2 Un-audited): Consolidated EPS was Tk. 0.97 for October-December, 2017 as against Tk. 1.29 for October-December, 2016; Consolidated EPS was Tk. 2.07 for July-December, 2017 as against Tk. 2.46 for July-December, 2016. Consolidated NOCFPS was Tk. 4.81 for July-December, 2017 as against Tk. 3.22 for July-December, 2016. (cont.)

ORIONPHARM 15-Nov-2017

(Q1 Un-audited): Consolidated EPS was Tk. 1.10 for July-September, 2017 as against Tk. 1.17 for July-September, 2016; Consolidated NOCFPS was Tk. 2.53 for July-September, 2017 as against Tk. 1.33 for July-September, 2016. Consolidated NAV per share (including revaluation surplus) was Tk. 72.05 as on September 30, 2017 and Tk. 71.09 as on September 30, 2016. Consolidated NAV per share (excluding revaluation surplus) was Tk. 63.62 as on September 30, 2017 and Tk. 62.51 as on September 30, 2016.

ORIONPHARM 08-Nov-2017

The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2017. Date of AGM: 14.12.2017, Time: 10:30 AM, Venue: Officer's Club, 26, Baily Road, Ramna, Dhaka. Record Date: 29.11.2017. The Company has also reported Consolidated EPS of Tk. 3.40, Consolidated NAV per share (including Revaluation Surplus) of Tk. 70.95 and Consolidated NOCFPS of Tk. 9.62 for the year ended on June 30, 2017 as against Tk. 5.65, Tk. 69.99 and Tk. 16.62 respectively for the year ended on June 30, 2016.

ORIONPHARM 02-May-2017

(Q3 Un-audited): Consolidated EPS was Tk. 0.56 for January-March 2017 as against Tk. 0.33 for January-March 2016; Consolidated EPS was Tk. 3.02 for July'16-March'17 as against Tk. 2.33 for July'15-March'16. Consolidated NOCFPS was Tk. 8.54 for July 2016-March 2017 as against Tk. 10.23 for July 2015-March 2016. Consolidated NAV per share (including and excluding Revaluation Surplus) was Tk. 71.14 and Tk. 62.63 respectively as on March 31, 2017 and Tk. 69.99 and Tk. 61.34 respectively as on June 30, 2016.

ORIONPHARM 01-Feb-2017

(Q2 Un-audited): Consolidated EPS was Tk. 1.29 for October-December, 2016 as against Tk. 1.27 for October-December, 2015; Consolidated EPS was Tk. 2.46 for July-December, 2016 as against Tk. 2.00 for July-December, 2015. Consolidated NOCFPS was Tk. 3.22 for July-December, 2016 as against Tk. 4.71 for July-December, 2015. (cont.)

ORIONPHARM 15-Nov-2016

(Q1 Un-audited): Consolidated EPS was Tk. 1.17 for July-September, 2016 as against Tk. 0.73 for July-September, 2015; Consolidated NOCFPS was Tk. 1.33 for July-September, 2016 as against Tk. 1.08 for July-September, 2015. Consolidated NAV per share was Tk. 71.09 as of September 30, 2016 and Tk. 69.48 as of September 30, 2015.

ORIONPHARM 13-Nov-2016

The Board of Directors has recommended 15% cash dividend for 18 months period from Jan 01, 2015 to June 30, 2016. Date of AGM: 20.12.2016, Time: 10:30 AM, Venue: Officer's Club, 26 Baily Road, Dhaka, Record Date: 01.12.2016. The Company has also reported Consolidated EPS of Tk. 5.65, Consolidated NAV per share of Tk. 69.99 and Consolidated NOCFPS of Tk. 16.62 for 18 months period from Jan 01, 2015 to June 30, 2016.

ORIONPHARM 01-Nov-2015

(Q3 Un-audited): Consolidated EPS was Tk. 0.73 for July- September, 2015 as against Tk. 0.77 for July- September., 2014; Consolidated EPS was Tk. 2.88 for January-September, 2015 as against Tk. 3.80 for January-September, 2014. Consolidated NOCFPS was Tk. 5.40 for January-September, 2015 as against Tk. 8.45 for January-September, 2014. (cont.)

ORIONPHARM 30-Jul-2015

(Q2 Un-audited): Consolidated EPS for April-June, 2015 was Tk. 0.74 as against Tk. 1.40 for April-June, 2014, Consolidated EPS for Jan-June, 2015 was Tk. 2.15 as against Tk. 3.03 for Jan-June, 2014. Consolidated NOCFPS was Tk. 4.32 for Jan-June, 2015 as against Tk. 6.81 for Jan-June, 2014. (cont.)

ORIONPHARM 17-May-2015

(Q1 Un-audited): Consolidated Net Profit after tax (excluding non controlling interest) from Jan'15 to March'15 was Tk. 330.26 million with consolidated EPS of Tk. 1.41 as against Tk. 380.80 million and Tk. 1.63 respectively for the same period of the previous year.

Previous Next page